Full name
REGIONALNY OŚRODEK DIAGNOSTYKI I LECZENIA CHORÓB NOWOTWOROWYCH "VEGAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
REGIONALNY OŚRODEK DIAGNOSTYKI I LECZENIA CHORÓB NOWOTWOROWYCH "VEGAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ZWYCIĘSTWA 25 / 3, 41-200 SOSNOWIEC
TAX ID6443258195
Rate company:
REGIONALNY OŚRODEK DIAGNOSTYKI I LECZENIA CHORÓB NOWOTWOROWYCH "VEGAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6443258195
KRS0000239831
Share capital50,000.00 zł
address
UL. ZWYCIĘSTWA 25 / 3, 41-200 SOSNOWIEC
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6443258195
REGON
240160321
KRS
0000239831
Legal form
limited liability company
Register Address
UL. ZWYCIĘSTWA 25 / 3, 41-200 SOSNOWIEC
Date of registration in KRS
2005-08-23
Date of commencement of economic activity
2005-08-23
Act signature
KA.VIII NS-REJ.KRS/35296/24/887
Pkd codes
86.21.Z - General medical practice activities
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
68.20.Z - Rental and operating of own or leased real estate
72.19.Z - Other research and experimental development on natural sciences and engineering
86.10.Z - Hospital activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.B - Emergency ambulance activities
Payer VAT status
exempted
Vat list bank account(s)
PL69 1020 2498 0000 8402 0529 6738 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0 | 0,1 | 0,1 | 20,4 |
EBITDA | -0 | 0,1 | 0,1 | 25,2 |
Short time liabilities | 0 | 0,1 | 0,1 | 4,5 |
Equity capital | 0 | 0,1 | 0,2 | 86,7 |
Operating profit (EBIT) | -0 | 0,1 | 0,1 | 22,4 |
Assets | 0,1 | 0,2 | 0,3 | 36 |
Net profit (loss) | -0 | 0,1 | 0,1 | 11,3 |
Cash | 0 | 0,2 | 0,2 | 7,9 |
Net income from sale | 0,1 | 1 | 1,3 | 28,2 |
Liabilities and provisions for liabilities | 0 | 0,1 | 0,1 | -19,5 |
Working assets | 0,1 | 0,2 | 0,3 | 19,6 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -29,9 | 77,9 | 46,4 | -31,5 |
Equity capital to total assets | 40,3 | 52,3 | 71,7 | 19,4 |
Gross profit margin | -10,7 | 9,1 | 8,6 | -0,5 |
EBITDA Margin | -10,7 | 9,1 | 8,9 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 69 | 29 | 24 | -5 |
Current financial liquidity indicator | 4.691534996032715 | 2.719383478164673 | 3.1131110191345215 | 0,4 |
Net dept to EBITDA | 2.25795841217041 | -1.991089940071106 | -1.961246132850647 | 0 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
SPÓŁKA LEKARSKA NA KOZŁÓWCE
Kraków
Lekarz
Jelenia Góra
Kamila Jabłońska
Toruń
Provita Sp. z o.o.
Katowice
MKF Medical sp. z o.o. sp.k.
Gdynia